Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Mini

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Journal of Inorganic Biochemistry|December 17, 2011
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative propertiesLaura Maiore, Maria Agostina Cinellu, Stefania Nobili, et al.
Expert Review of Clinical Pharmacology|July 22, 2021
Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinomaMartina Catalano, Andrea Casadei-Gardini, Gianmarco Vannini, et al.
Journal of Medicinal Chemistry|September 1, 2006
Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligandsAngela Casini, Maria Agostina Cinellu, Giovanni Minghetti, et al.
Journal of Medicinal Chemistry|October 14, 2005
Mechanisms of cytotoxicity of selected organogold(III) compoundsMarcella Coronnello, Enrico Mini, Barbara Caciagli, et al.
Immunotherapy|April 5, 2022
Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature reviewValeria Emma Palmieri, Giandomenico Roviello, Martina Catalano, et al.
Journal of Personalized Medicine|March 25, 2022
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and TherapyFatemeh Ghorbani Parsa, Stefania Nobili, Mina Karimpour, et al.
Critical Reviews in Oncology/Hematology|June 11, 2020
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directionsGiandomenico Roviello, Alberto D'Angelo, Marianna Sciortino, et al.
Bioorganic & Medicinal Chemistry|November 3, 2004
Solution chemistry and cytotoxic properties of novel organogold(III) compoundsLuigi Messori, Giordana Marcon, Maria Agostina Cinellu, et al.
Molecular and Clinical Oncology|December 15, 2018
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumorsAlessandro Villanucci, Ketty Tavella, Laura Vannini, et al.
Colloids and Surfaces. B, Biointerfaces|January 28, 2014
Strategy to provide a useful solution to effective delivery of dihydroartemisinin: development, characterization and in vitro studies of liposomal formulationsChiara Righeschi, Marcella Coronnello, Azzurra Mastrantoni, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Journal of Inorganic Biochemistry|December 17, 2011
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative propertiesLaura Maiore, Maria Agostina Cinellu, Stefania Nobili, et al.
Expert Review of Clinical Pharmacology|July 22, 2021
Lenvatinib: established and promising drug for the treatment of advanced hepatocellular carcinomaMartina Catalano, Andrea Casadei-Gardini, Gianmarco Vannini, et al.
Journal of Medicinal Chemistry|September 1, 2006
Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligandsAngela Casini, Maria Agostina Cinellu, Giovanni Minghetti, et al.
Journal of Medicinal Chemistry|October 14, 2005
Mechanisms of cytotoxicity of selected organogold(III) compoundsMarcella Coronnello, Enrico Mini, Barbara Caciagli, et al.
Immunotherapy|April 5, 2022
Immune checkpoint inhibitor-induced neurologic toxicity: a case report and literature reviewValeria Emma Palmieri, Giandomenico Roviello, Martina Catalano, et al.
Journal of Personalized Medicine|March 25, 2022
Fanconi Anemia Pathway in Colorectal Cancer: A Novel Opportunity for Diagnosis, Prognosis and TherapyFatemeh Ghorbani Parsa, Stefania Nobili, Mina Karimpour, et al.
Critical Reviews in Oncology/Hematology|June 11, 2020
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directionsGiandomenico Roviello, Alberto D'Angelo, Marianna Sciortino, et al.
Bioorganic & Medicinal Chemistry|November 3, 2004
Solution chemistry and cytotoxic properties of novel organogold(III) compoundsLuigi Messori, Giordana Marcon, Maria Agostina Cinellu, et al.
Molecular and Clinical Oncology|December 15, 2018
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumorsAlessandro Villanucci, Ketty Tavella, Laura Vannini, et al.
Colloids and Surfaces. B, Biointerfaces|January 28, 2014
Strategy to provide a useful solution to effective delivery of dihydroartemisinin: development, characterization and in vitro studies of liposomal formulationsChiara Righeschi, Marcella Coronnello, Azzurra Mastrantoni, et al.
Pageof 14